share_log

JMP Securities Reiterates Market Outperform on Sutro Biopharma, Maintains $17 Price Target

Moomoo 24/7 ·  Apr 3 08:23

JMP Securities analyst Reni Benjamin reiterates Sutro Biopharma (NASDAQ:STRO) with a Market Outperform and maintains $17 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment